News Alerts:

Developing your Medtech IP & Commercialisation Strategies

4th October - 13:00-15:00

This two hour course is suitable for anyone from the NHS, academia or industry with an interest in intellectual property (IP) and the commercialisation of medical technologies. It will help you understand IP strategy development and how to translate an idea into a viable product or service.

Topics covered will include:

  • An introduction to the basic concepts of IP and why IP is important.
  • An overview of different types of IP rights, their key features, and their likely uses.
  • The innovation process, from idea to market.
  • Key aspects to consider along your innovation journey.
  • Commercialisation strategies (eg licensing vs spin out company).
  • Post-implementation considerations and market access plans.
  • Funding support for innovators.
  • Case studies.

Who would benefit from attending?

This course is suitable for any innovator developing new healthcare products and services including professionals working in:

  • Research and development
  • Commercial teams
  • Business development
  • Technology transfer
  • Start-ups and SMEs
  • The NHS and academia

Course Fees

Industry Fees: £45 +VAT

Public Sector: £25 + VAT

NHS Staff: Free with an NHS email (contact us to secure your place –

Places are limited and allocated on a first-come, first-served basis.


Meet the Speakers

Dr Anne Blackwood, Chief Executive, Health Tech Enterprise

Anne has over 20 years experience in commercialising life science innovations and a proven track record in raising seed financing and investment for early stage technologies.

Dr Karen Law, Head of Innovation, Health Tech Enterprise

Karen is an experienced IP and commercialisation professional having over 14 years’ experience of leading the identification, evaluation, protection, development, and commercialisation of innovations developed by research scientists and clinicians. She has negotiated numerous licensing agreements for a diverse range of technologies including therapeutics and devices.

Stay in Touch:

Keep up to date with all HTE news and events.

Subscribe to our mailing list